BriaCell Therapeutics Corp Cash Flow Quality Index

Latest as of April 2024: -3.00x

BriaCell Therapeutics Corp cash flow quality index. BriaCell Therapeutics Corp (BCTXW) has a Cash Flow Quality Index of -3.00x as of April 2024. Operating cash flow of $-5.08 Million is below net income of $1.69 Million, suggesting accrual-heavy earnings not yet converted to cash. See BriaCell Therapeutics Corp (BCTXW) flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-3.00x
Operating CF / Net Income

Operating Cash Flow

$-5.08 Million
USD

Net Income

$1.69 Million
USD

Data as of

Apr 2024
Most recent filing

BriaCell Therapeutics Corp Cash Flow Quality Index by Year (None–None)

BriaCell Therapeutics Corp cash flow quality index by year from None to None. Year-by-year earnings quality comparison for BriaCell Therapeutics Corp. For the full cash flow conversion analysis, see BriaCell Therapeutics Corp (BCTXW) cash conversion ratio.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.